Fund profile / France

Kurma Partners

Geography: France
Stage: Seed
Fund size: €140M
Focus: Deep Tech and SaaS
Signals: Published

N°01 / About

About Kurma Partners

Kurma Partners is a venture capital firm based in France, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

N°02 / Thesis

Investment Focus

Location / RegionFrance

Funding StageSeed

Industry Focus

Deep Tech

SaaS

Investor Signals Profile

active

Sweet Spot

Scientific founder, European academic IP, severe disease, pre-seed

biotech-early-stage

company-creation

rare-disease

therapeutics

europe-focus

digital-health-adjacent

Bullish Signals

4 Big Pharma exits from Fund IIIblog

CSL anchors as strategic pharma LPblog

11 portfolio companies already deployedblog

€1B AUM crossed, first timeblog

Munich office open, Max Planck spinout dealtwitter

Active in Dx, diagnostics deals 2017–18twitter

Biofund III first close announcedtwitter

Biofund IV final close €215Mlinkedin

Bpifrance, EIF, SFPIM as LP anchorslinkedin

Target 20 portfolio companies, Biofund IVlinkedin

Part of Eurazeo group — institutional backinglinkedin

Memo Therapeutics acquired by Ipsen €700M+linkedin

Memo: co-led Series C, first-class antibodylinkedin

Potravitug solves unmet BK polyomavirus needlinkedin

Minoryx Nezglyal CHMP approval, rare diseaselinkedin

Biofund II portfolio exits advancing regulatorylinkedin

Minoryx Nezglyal positive CHMP opinion Europelinkedin

Biofund II portfolio achieving regulatory milestoneslinkedin

Digital Health & Boat 4th edition hostedlinkedin

AWS, Goodwin, Scarlet partners support ecosystemlinkedin

Active ecosystem convening, Europe healthcare leaderslinkedin

Contrarian Signals

Missed €250M target by €35Mblog

10–12 year horizon, slow exitsblog

Binary clinical risk, 80% therapeuticsblog

Biofund IV below €250M target againlinkedin

Founder Do's

Come pre-formation — Kurma engages early

Have academic or research institute roots

Target severe or rare diseases

Be open to hands-on co-building

Therapeutics focus (oncology, immunology, gene therapy)

Attend Kurma ecosystem events (Digital Health & Boat)

Founder Don'ts

Don't pitch without clear unmet medical need

Don't expect passive capital — they co-build

Don't pitch growth-stage SaaS or digital health

46 signals on Kurma Partners

21 bullish · 4 contrarian · 6 pitch do's · 3 don'ts · 12 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size€140M

Saves0

Website

People

Key People

Remi Droller, Thierry Laugel

Jacques ChatainDirecteur Général / Founder

Jim CowartManaging Partner

Hadrien BouchezPartner

Daniel PareraPrincipal

Peter NeubeckPartner

Thierry LaugelPartner

Rémi DrollerPartner

Amanda Gett-ChaperotPartner

Florence de CoorebyterPartner

Ania TchorzewskaPartner

Philippe PeltierPartner

Benjamin BelotTeam Member

N°04 / See also

Related Funds

Capagro

Fund size€115M

Location: France
Stage: Series A
Focus: Saas
Manager: Tom Espiard Cignaco, Maxime Walter

Series A

Saas

Serena Fund IV

Fund size€200M

Location: France
Stage: Seed
Focus: Ai Ml, Climate Sustainability, Energy Tech
Manager: Xavier Lorphelin, Marc Fournier, Philippe Hayat

Seed

Ai Ml

Climate Sustainability

Energy Tech

Kurma Partners Biofund IV

Fund size€215M

Location: France
Stage: Series A
Focus: Biotech, Therapeutics
Manager: Vanessa Malier

Series A

Biotech

Therapeutics